Overview
News
Salaries
Products
People
Growth
Offices
Financials

Overview

HyTest offers innovative solutions for assay development and research applications by providing high-quality immunological reagents in such areas as cardiac markers, Troponin I and Troponin T, infectious disease antibodies and autoimmune disease reagents.

News

News PE Hub 5 years ago
Summa Equity to sell HyTest to Mindray
Summa Equity has agreed to sell HyTest to Mindray for 545 million euros.
Read more
Report
News PE Hub 8 years ago
Summa Equity buys Finnish antibody manufacturer HyTest
Summa Equity has acquired Finnish antibody manufacturer HyTest. No financial terms were disclosed.
Read more
Report

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Turku Finland
HQ
20520 Turku, Finland
20520 Turku, Finland
company site